<DOC>
	<DOCNO>NCT01469624</DOCNO>
	<brief_summary>Contrast induce nephropathy ( CIN ) great concern use contrast medium new era medicine . CIN define 25-50 % relative increase , 0.5-1 absolute increase serum creatinin value 25 % fall GFR . The incidence CIN find 0 % 10 % general population 50 % high risk population . High risk patient include chronic kidney disease ( GFR &lt; 60 ml/min/1.73 mÂ² ) Diabetes Mellitus , congestive heart failure , anemia advance age . Amount kind contrast medium decrease circulate blood volume important predictor CIN . 50 % case CIN happen within 24 hour contrast injection . Maximum creatinin level reach 48-72 hour . It usually return previous level 7-10 day . Suggested mechanisms renal vasoconstriction tubular injury . N-acetylcysteine hydration prove protective CIN theophylline may role . In study , hypothesize pentoxifylline , dimethylxanthine , also protect renal cell CIN . It observe pentoxifylline improves oxygen delivery ischemic tissue , diminishes oxidative damage renal tissue may also scavenge free radical . Percutaneous coronary intervention assume high risk procedure develop CIN amount contrast use PCI remarkable . Therefore , patient undergo PCI select trial . A prospective randomize trial conduct patient undergo PCI .</brief_summary>
	<brief_title>Evaluating Protective Effect Pentoxifylline Contrast Induced Nephropathy</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Pentoxifylline</mesh_term>
	<criteria>All eligible consecutive patient admit angiography center university hospital PCI since April 2011 enrol enter study . Serum creatinine 1.5 mg/dl Frank bleeding tendency Those previously pentoxifylline</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2011</verification_date>
	<keyword>Contrast Induced Nephropathy</keyword>
	<keyword>Pentoxifylline</keyword>
	<keyword>PCI</keyword>
</DOC>